Ad is loading...
RYVLX
Price
$571.07
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
UUPSX
Price
$44.98
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

RYVLX vs UUPSX

Header iconRYVLX vs UUPSX Comparison
Open Charts RYVLX vs UUPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy A
Price$571.07
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ProFunds UltraEmerging Markets Svc
Price$44.98
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RYVLX vs UUPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYVLX vs. UUPSX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVLX is a StrongBuy and UUPSX is a Sell.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.38B vs. UUPSX (6.74M). UUPSX pays higher dividends than RYVLX: UUPSX (0.84) vs RYVLX (0.00). RYVLX was incepted earlier than UUPSX: RYVLX (20 years) vs UUPSX (19 years). RYVLX is a more actively managed with annual turnover of: 461.00 vs. UUPSX (292.00). RYVLX has a lower initial minimum investment than UUPSX: RYVLX (2500) vs UUPSX (15000). RYVLX annual gain was more profitable for investors over the last year : 53.22 vs. UUPSX (23.73). RYVLX return over 5 years is better than : 212.88 vs. UUPSX (-11.94).
RYVLXUUPSXRYVLX / UUPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years19 years-
Gain YTD39.61911.144356%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B6.74M20,517%
Annual Yield % from dividends0.000.84-
Returns for 1 year53.2223.73224%
Returns for 3 years10.72-25.14-43%
Returns for 5 years212.88-11.94-1,783%
Returns for 10 years655.52-21.05-3,115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK14.680.48
+3.38%
Park Hotels & Resorts
VITL31.030.90
+2.99%
Vital Farms
PTC192.754.25
+2.25%
PTC
ZNTL3.180.05
+1.60%
Zentalis Pharmaceuticals
BOLT0.57N/A
-0.56%
Bolt Biotherapeutics